Table 4. Neuropsychological test scores at baseline and follow-up in PD patients.
| PD without cognitive decline (N=15) | PD with cognitive decline (N=13) | F | P valuea | ||||
|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | ||||
| MMSE | 27.66±2.41 | 28.33±1.75 | 28.92±1.49 | 27.30±2.05 | 7.690 | <0.001 | |
| MoCA | 26.00±1.19 | 26.08±1.32 | 26.76±1.73 | 23.92±3.42 | 15.832 | 0.001 | |
a, values in bold indicate significant results from repeated-measures ANOVA by mixed-effects model. MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; PD, Parkinson’s disease.